NO924246L - Fremgangsmaater og reagenser for hla klasse i dna-type-bestemmelse - Google Patents

Fremgangsmaater og reagenser for hla klasse i dna-type-bestemmelse

Info

Publication number
NO924246L
NO924246L NO92924246A NO924246A NO924246L NO 924246 L NO924246 L NO 924246L NO 92924246 A NO92924246 A NO 92924246A NO 924246 A NO924246 A NO 924246A NO 924246 L NO924246 L NO 924246L
Authority
NO
Norway
Prior art keywords
hla class
procedures
reagents
dna
type determination
Prior art date
Application number
NO92924246A
Other languages
English (en)
Norwegian (no)
Other versions
NO924246D0 (no
Inventor
Teodorica Bugawan
Henry A Erlich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO924246D0 publication Critical patent/NO924246D0/no
Publication of NO924246L publication Critical patent/NO924246L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO92924246A 1991-11-05 1992-11-04 Fremgangsmaater og reagenser for hla klasse i dna-type-bestemmelse NO924246L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78811391A 1991-11-05 1991-11-05

Publications (2)

Publication Number Publication Date
NO924246D0 NO924246D0 (no) 1992-11-04
NO924246L true NO924246L (no) 1993-05-06

Family

ID=25143482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924246A NO924246L (no) 1991-11-05 1992-11-04 Fremgangsmaater og reagenser for hla klasse i dna-type-bestemmelse

Country Status (13)

Country Link
US (1) US5451512A (pt)
EP (1) EP0540997A1 (pt)
JP (1) JPH0866197A (pt)
KR (1) KR930010192A (pt)
CN (1) CN1073484A (pt)
AU (1) AU2748592A (pt)
BR (1) BR9204280A (pt)
CA (1) CA2081582A1 (pt)
FI (1) FI924999A (pt)
IL (1) IL103602A0 (pt)
NO (1) NO924246L (pt)
NZ (1) NZ244924A (pt)
ZA (1) ZA928374B (pt)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
WO1992015711A1 (en) * 1991-03-06 1992-09-17 Regents Of The University Of Minnesota Dna sequence-based hla typing method
EP1382386A3 (en) * 1992-02-19 2004-12-01 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
DE69412470T3 (de) * 1993-03-18 2006-07-20 Naamloze Vennootschap Innogenetics S.A. Verfahren zur hla-b typisierung mittels spezifischer primer und probensätze
US5834189A (en) * 1994-07-08 1998-11-10 Visible Genetics Inc. Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of HLA types
US6103465A (en) * 1995-02-14 2000-08-15 The Perkin-Elmer Corporation Methods and reagents for typing HLA class I genes
US5550039A (en) * 1995-03-07 1996-08-27 Hoffmann-La Roche Inc. Oligonucleotide primers for HLA class I B locus DNA typing
GB9524381D0 (en) * 1995-11-29 1996-01-31 Anthony Nolan Bone Marrow Trus Method for identifying an unknown allele
US6007983A (en) * 1995-12-22 1999-12-28 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US6265152B1 (en) 1995-12-22 2001-07-24 Visible Genetics Inc. Method and kit for evaluation of HIV mutations
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
AU694327B2 (en) * 1996-02-20 1998-07-16 Applera Corporation Methods and reagents for typing HLA class I genes
CA2274737A1 (en) * 1996-12-12 1998-06-18 Visible Genetics, Inc. Method and kit for hla class i typing
US6287764B1 (en) 1997-02-11 2001-09-11 William H. Hildebrand Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing
US6830887B2 (en) 1997-03-18 2004-12-14 Bayer Healthcare Llc Method and kit for quantitation and nucleic acid sequencing of nucleic acid analytes in a sample
DE19715430A1 (de) * 1997-04-14 1998-11-26 Boehringer Mannheim Gmbh Verfahren zur Typisierung von Allelen
WO1999005313A2 (en) * 1997-07-23 1999-02-04 Rijksuniversiteit Leiden Method for typing of minor histocompatibility antigen ha-1
US5910413A (en) * 1997-10-10 1999-06-08 Visible Genetics, Inc. Method and kit for amplification, sequencing and typing of classical HLA class I genes
EP0953650A1 (en) * 1998-04-20 1999-11-03 Innogenetics N.V. Method for typing of HLA alleles
WO2000079006A1 (en) * 1999-06-17 2000-12-28 Fred Hutchinson Cancer Research Center Oligonucleotide arrays for high resolution hla typing
US6670124B1 (en) * 1999-12-20 2003-12-30 Stemcyte, Inc. High throughput methods of HLA typing
US7829313B2 (en) * 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US7875442B2 (en) * 2000-03-24 2011-01-25 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US20080085515A1 (en) * 2000-03-24 2008-04-10 Eppendorf Array Technologies Sa (Eat) Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
US7205104B2 (en) * 2000-03-24 2007-04-17 Eppendorf Array Technologies Sa (Eat) Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
US7202026B2 (en) * 2000-03-24 2007-04-10 Eppendorf Array Technologies Sa (Eat) Identification of a large number of biological (micro)organisms groups at different levels by their detection on a same array
US20030228585A1 (en) * 2000-06-01 2003-12-11 Hidetoshi Inoko Kit and method for determining hla type
EP1164201A1 (en) * 2000-06-14 2001-12-19 Facultés Universitaires Notre-Dame de la Paix Reverse detection for identification and/or quantification of nucleotide target sequences on biochips
CN1295745C (zh) * 2001-05-23 2007-01-17 马特森热力产品有限责任公司 用于热处理衬底的方法和装置
US7732138B2 (en) * 2001-11-07 2010-06-08 Diagcor Bioscience Incorporation Limited Rapid genotyping analysis and the device thereof
US20040241723A1 (en) * 2002-03-18 2004-12-02 Marquess Foley Leigh Shaw Systems and methods for improving protein and milk production of dairy herds
US20040126794A1 (en) * 2002-09-26 2004-07-01 Bugawan Teodorica L. Detection of susceptibility to autoimmune diseases
EP1606419A1 (en) 2003-03-18 2005-12-21 Quantum Genetics Ireland Limited Systems and methods for improving protein and milk production of dairy herds
US7820030B2 (en) 2003-04-16 2010-10-26 Handylab, Inc. System and method for electrochemical detection of biological compounds
ITMI20031627A1 (it) * 2003-08-07 2005-02-08 Nuclear Laser Medicine S R L Metodo e kit per diagnosticare la predisposizione genetica degli ovini alla scrapie.
EP1536021A1 (en) * 2003-11-27 2005-06-01 Consortium National de Recherche en Genomique (CNRG) Method for HLA typing
JP4518784B2 (ja) * 2003-12-01 2010-08-04 Ｇ＆Ｇサイエンス株式会社 新規遺伝子型判定方法
WO2005063985A1 (en) 2003-12-25 2005-07-14 Canon Kabushiki Kaisha Probe set and method for identifying hla allele
US20050202484A1 (en) 2004-02-19 2005-09-15 The Governors Of The University Of Alberta Leptin promoter polymorphisms and uses thereof
US7338763B2 (en) * 2004-06-02 2008-03-04 Eppendorf Array Technologies S.A. Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
WO2007035836A2 (en) * 2005-09-20 2007-03-29 The Board Of Regents Of The University Of Oklahoma Accelerated class i and class ii hla dna sequence-based typing
EP1948827B1 (en) 2005-10-21 2016-03-23 The Regents of The University of California C-kit oncogene mutations in melanoma
US20070154895A1 (en) * 2005-12-30 2007-07-05 Caliper Life Sciences, Inc. Multi-assay microfluidic chips
AU2007257340A1 (en) * 2006-06-09 2007-12-13 Celera Corporation Identification of a nucleic acid molecule
US20090069190A1 (en) * 2006-10-17 2009-03-12 Invitrogen Corporation Methods for hla typing
EP2700723B1 (en) 2007-08-06 2015-07-15 Orion Genomics, LLC Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the IGF2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
US20100086914A1 (en) * 2008-10-03 2010-04-08 Roche Molecular Systems, Inc. High resolution, high throughput hla genotyping by clonal sequencing
US20100324154A1 (en) 2007-11-01 2010-12-23 Hageman Gregory S Assessing susceptibility to vascular disorders
US20100261189A1 (en) * 2008-10-03 2010-10-14 Roche Molecular Systems, Inc. System and method for detection of HLA Variants
CA2751758A1 (en) 2009-02-11 2010-08-19 Orion Genomics Llc Combinations of polymorphisms for determining allele-specific expression of igf2
DE202010003498U1 (de) 2010-03-11 2011-07-06 Jacobs University Bremen Ggmbh Gen codiert für ein MHC-Klasse-I-Molekül, Plasmid, Expressionssystem Protein, Multimer, Reagenz und Kit zum Analysieren einer T-Zellen-Frequenz
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
WO2012040619A2 (en) 2010-09-24 2012-03-29 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
WO2013030620A2 (de) 2011-08-30 2013-03-07 Jacobs University Bremen Ggmbh Gen codiert für ein mhc-klasse-i-molekül, plasmid, expressionssystem protein, multimer, reagenz und kit zum analysieren einer t-zellen-frequenz
WO2013030168A1 (en) 2011-08-31 2013-03-07 F. Hoffmann-La Roche Ag Method for predicting risk of hypertension associated with anti-angiogenesis therapy
MX2014002311A (es) 2011-08-31 2014-08-26 Hoffmann La Roche Capacidad de respuesta a inhibidores de angiogenesis.
AU2012312515A1 (en) 2011-09-19 2014-03-13 Genentech, Inc. Combination treatments comprising c-met antagonists and B-raf antagonists
EP2783015A1 (en) 2011-11-23 2014-10-01 F.Hoffmann-La Roche Ag Responsiveness to angiogenesis inhibitors
MY154507A (en) 2012-03-19 2015-06-22 Malaysian Palm Oil Board Gene Controlling Shell Phenotype in Palm
US10294529B2 (en) 2012-04-10 2019-05-21 Life Sciences Research Partners Vzw Microsatellite instability markers in detection of cancer
US10633707B2 (en) 2012-04-10 2020-04-28 Vib Vzw Markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway
US10077474B2 (en) 2012-05-29 2018-09-18 Abbott Molecular, Inc. Method of designing primers, method of detecting single nucleotide polymorphisms (SNPs), method of distinguishing SNPs, and related primers, detectable oligonucleotides, and kits
US20140272956A1 (en) 2013-03-15 2014-09-18 Abbott Molecular Inc. Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits
US10544461B2 (en) 2013-04-16 2020-01-28 The Johns Hopkins University Diagnostic and prognostic test for sturge-weber syndrome, klippel-trenaunay-weber syndrome, and port-wine stains (PWSS)
SG11201607772WA (en) 2014-03-31 2016-10-28 Debiopharm Int Sa Fgfr fusions
US9909187B2 (en) 2014-06-24 2018-03-06 Abbott Molecular Inc. Detection of single nucleotide polymorphisms in human KRAS
JP7231326B2 (ja) 2014-11-10 2023-03-01 ジェネンテック， インコーポレイテッド Ｉｌ－３３媒介性障害のための治療及び診断方法
JP7418337B2 (ja) 2018-02-09 2024-01-19 ジェネンテック， インコーポレイテッド マスト細胞媒介性炎症性疾患の治療法及び診断法
US20230110203A1 (en) 2020-03-13 2023-04-13 Medimmune Limited Therapeutic methods for the treatment of subjects with risk alelles in il33

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
JPS62228300A (ja) * 1986-01-03 1987-10-07 モレキユラ−・ダイアグノステイツクス・インコ−ポレ−テツド 真核生物のゲノムｄｎａのドツト−ブロツト交雑法
US5310893A (en) * 1986-03-31 1994-05-10 Hoffmann-La Roche Inc. Method for HLA DP typing
JPH0249589A (ja) * 1988-08-11 1990-02-19 Olympus Optical Co Ltd Ｈｌａクラスｉｄｎａおよびｄｎａプローブ並びに形質転換細胞
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
GB9024005D0 (en) * 1990-11-05 1990-12-19 British Bio Technology Process for amplifying nucleic acid
US5424184A (en) * 1991-05-08 1995-06-13 Regents Of The University Of Minnesota DNA sequence-based HLA class I typing method

Also Published As

Publication number Publication date
BR9204280A (pt) 1993-05-11
ZA928374B (en) 1993-05-13
CA2081582A1 (en) 1993-05-06
EP0540997A1 (en) 1993-05-12
FI924999A (fi) 1993-05-06
JPH0866197A (ja) 1996-03-12
NO924246D0 (no) 1992-11-04
AU2748592A (en) 1993-05-06
US5451512A (en) 1995-09-19
NZ244924A (en) 1994-07-26
CN1073484A (zh) 1993-06-23
IL103602A0 (en) 1993-03-15
KR930010192A (ko) 1993-06-22
FI924999A0 (fi) 1992-11-05

Similar Documents

Publication Publication Date Title
NO924246L (no) Fremgangsmaater og reagenser for hla klasse i dna-type-bestemmelse
Rohlfs et al. An Alu‐mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10
Hyland et al. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes
Kyogoku et al. Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A
Leppers-Van de Straat et al. A novel PCR-based method for direct Fcγ receptor IIIa (CD16) allotyping
Matsushita et al. Lack of a strong association of CTLA‐4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method
US20050009016A1 (en) Tgfbeta-rII promoter polymorphisms
CA2075037A1 (en) Methods and reagents for hla drbeta dna typing
CA2075052A1 (en) Hla dqbeta dna typing
Emara et al. Genetic diversity at the major histocompatibility complex (B) and microsatellite loci in three commercial broiler pure lines
Harteveld et al. α-Thalassemia in The Netherlands: a heterogeneous spectrum of both deletions and point mutations
Weitkamp et al. Ancestral and recombinant 16-locus HLA haplotypes in the Hutterites
ES2445709T3 (es) Método para la identificación por técnicas moleculares de variantes genéticas que no codifican antígeno D (D-) y codifican antígeno C alterado (C+W)
Campbell et al. Rapid genotyping of mutant mice using dried blood spots for polymerase chain reaction (PCR) analysis
EP2707497B1 (en) Detecting the brachyspina mutation
CN1120889C (zh) 诊断遗传性贫血相关基因突变的dna芯片
ES2884474T3 (es) Determinación del genotipo subyacente al fenotipo S-s-U- del sistema de grupo sanguíneo MNSs
CN111593115A (zh) 用于β-地中海贫血基因突变多重实时荧光PCR检测的引物和探针组合及试剂盒
US6534272B2 (en) DNA assay for the prediction of autoimmune diabetes
AU2001260263B2 (en) Method and probes for the genetic diagnosis of hemochromatosis
CN108823309B (zh) 检测kiaa0125基因表达水平的物质在辅助鉴定急性淋巴细胞白血病中的应用
Sutton et al. An abnormal DRB4 (DRw53) mRNA is produced by DR7 individuals who fail to express the gene product
Holden et al. Conference Report: Eighth International Workshop on the Fragile X Syndrome and X-Linked Mental Retardation, August 16-22, 1997
McKenzie Marsupial genetics studied in tammar, parma and black-striped wallabies: Mapping, conservation and evolution
CN1335409A (zh) 检测6－磷酸葡萄糖脱氢酶基因突变的dna芯片